[go: up one dir, main page]

NO975851L - Cytoplasmatiske modulatorer av integrinregulering/-signalisering - Google Patents

Cytoplasmatiske modulatorer av integrinregulering/-signalisering

Info

Publication number
NO975851L
NO975851L NO975851A NO975851A NO975851L NO 975851 L NO975851 L NO 975851L NO 975851 A NO975851 A NO 975851A NO 975851 A NO975851 A NO 975851A NO 975851 L NO975851 L NO 975851L
Authority
NO
Norway
Prior art keywords
modulators
irp
signaling
cytoplasmic
polypeptides
Prior art date
Application number
NO975851A
Other languages
English (en)
Norwegian (no)
Other versions
NO975851D0 (no
Inventor
Donald E Staunton
Brian P Lipsky
Original Assignee
Icos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icos Corp filed Critical Icos Corp
Publication of NO975851D0 publication Critical patent/NO975851D0/no
Publication of NO975851L publication Critical patent/NO975851L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • C12N5/12Fused cells, e.g. hybridomas
    • C12N5/16Animal cells
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO975851A 1996-04-15 1997-12-12 Cytoplasmatiske modulatorer av integrinregulering/-signalisering NO975851L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63224796A 1996-04-15 1996-04-15
PCT/US1997/006272 WO1997039124A1 (en) 1996-04-15 1997-04-15 Cytoplasmic modulators of integrin regulation/signaling

Publications (2)

Publication Number Publication Date
NO975851D0 NO975851D0 (no) 1997-12-12
NO975851L true NO975851L (no) 1998-02-16

Family

ID=24534733

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975851A NO975851L (no) 1996-04-15 1997-12-12 Cytoplasmatiske modulatorer av integrinregulering/-signalisering

Country Status (15)

Country Link
US (3) US5958705A (zh)
EP (1) EP0833910A1 (zh)
JP (1) JPH10511559A (zh)
CN (1) CN1195374A (zh)
AU (1) AU724246B2 (zh)
BR (1) BR9702143A (zh)
CA (1) CA2224571A1 (zh)
CZ (1) CZ398197A3 (zh)
HU (1) HUP9901757A3 (zh)
IL (1) IL122557A0 (zh)
MX (1) MX9710010A (zh)
NO (1) NO975851L (zh)
PL (1) PL323998A1 (zh)
SK (1) SK170497A3 (zh)
WO (1) WO1997039124A1 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19534120A1 (de) * 1995-09-14 1997-03-20 Hoechst Ag Verwendung von Cytohesin-PH-Peptiden zur Beeinflußung der Adhäsionsfähigkeit von Integrinen
US6221841B1 (en) 1996-10-07 2001-04-24 University Of Massachusetts Medical Center General receptors for phosphoinositides and uses related thereto
US6342345B1 (en) * 1997-04-02 2002-01-29 The Board Of Trustees Of The Leland Stanford Junior University Detection of molecular interactions by reporter subunit complementation
AU5603000A (en) * 1999-06-09 2000-12-28 Icos Corporation Interaction of b3-1 with adp-ribosylation factor gtp exchange factors
US20020004247A1 (en) * 1999-12-23 2002-01-10 Genentech, Inc. Assay method
DE60117743T2 (de) * 2001-11-05 2006-10-12 Warner-Lambert Co. Llc Screeningverfahren für Modulatoren von Integrinen
US20040228800A1 (en) * 2003-05-15 2004-11-18 Scicotec Gmbh Non-invasive identification of patients at increased risk for myocardial infarction
MX2018001668A (es) 2015-08-11 2018-05-07 Univ Osaka Anticuerpo.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2202851B (en) * 1987-03-24 1990-12-19 Nat Res Dev Proteinaceous material of p. haemolytica and vaccine against pasteurella
US5470953A (en) * 1993-12-23 1995-11-28 Icos Corporation Human β2 integrin α subunit
US5561047A (en) * 1994-12-13 1996-10-01 The Trustees Of The University Of Pennsylvania Method of identifying effectors of integrin activation
DE19534120A1 (de) * 1995-09-14 1997-03-20 Hoechst Ag Verwendung von Cytohesin-PH-Peptiden zur Beeinflußung der Adhäsionsfähigkeit von Integrinen

Also Published As

Publication number Publication date
US5958705A (en) 1999-09-28
US6210914B1 (en) 2001-04-03
NO975851D0 (no) 1997-12-12
PL323998A1 (en) 1998-04-27
AU724246B2 (en) 2000-09-14
WO1997039124A1 (en) 1997-10-23
CN1195374A (zh) 1998-10-07
HUP9901757A2 (hu) 1999-08-30
EP0833910A1 (en) 1998-04-08
BR9702143A (pt) 1999-01-05
JPH10511559A (ja) 1998-11-10
SK170497A3 (en) 1998-09-09
MX9710010A (es) 1998-03-29
CZ398197A3 (cs) 1998-06-17
IL122557A0 (en) 1998-06-15
AU2802497A (en) 1997-11-07
US20030044958A1 (en) 2003-03-06
HUP9901757A3 (en) 2001-10-29
CA2224571A1 (en) 1997-10-23

Similar Documents

Publication Publication Date Title
BR9814611A (pt) Polipeptìdeos modificados dependentes de vitamina k
IL140937A0 (en) Molecules designated ldcam
ES2054019T5 (es) Procedimiento para la purificacion de proteinas dependientes de la vitamina k.
WO1999036550A3 (en) Human protease molecules
DE69939982D1 (de) B7l-1 moleküle
NO844898L (no) Fremgangsmaate og apparat for aa fordele kjemikalier for resning av vann
NO975851L (no) Cytoplasmatiske modulatorer av integrinregulering/-signalisering
TR200000662T2 (tr) Doğal-olmayan seçici agonistler kullanılarak kemik hacminin arttırılması yöntemi.
BR9909624A (pt) Linhagens de células do sistema nervoso periférico (pns) e processos de utilização para as memas
ATE259652T1 (de) Neuronale verwendungen des bmp-11
BR0206905A (pt) Métodos para tratar ou prevenir distúrbios da pele empregando-se agentes de ligação de cd2
EP1715035A3 (en) Synthetic polynucleotides encoding lysyl oxidase
ATE175442T1 (de) Therapie des zentralnervensystems mit genetisch modifizierten zellen
WO1998000770A3 (en) Encryption enhancement system
ATE98130T1 (de) Kombination von angiotensin-converting-enzymehemmern mit kaliumkanal-modulatoren sowie deren verwendung in arzneimitteln.
WO1999058558A3 (en) Cell signaling proteins
WO2002002603A3 (en) Protein modification and maintenance molecules
ATE288498T1 (de) Methoden zur inhibierung von helicobacter pylori
WO1999041373A3 (en) Human transport-associated molecules
BG98820A (en) Method and device for the expansion of tobacco
BR9407357A (pt) Novos tripeptideos utilizáveis em terapia cns e imune
NO995326L (no) Fremgangsmåte og apparat for behandling av et plateliknende materiale med et gassformig middel
WO1999043832A3 (en) Human proteinase molecules
NO971553D0 (no) Cytoplasmisk tyrosinkinase
WO1999051531A8 (en) Waste treatment system and method

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application